PNC Financial Services Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,052
| Closed | -$5K | – | 3952 |
|
|
2020
Q3 | $5K | Hold |
2,052
| – | – | ﹤0.01% | 3658 |
|
|
2020
Q2 | $28K | Buy |
+2,052
| New | +$28K | ﹤0.01% | 3046 |
|
|
2020
Q1 | – | Sell |
-110
| Closed | -$1K | – | 3875 |
|
|
2019
Q4 | $1K | Hold |
110
| – | – | ﹤0.01% | 3863 |
|
|
2019
Q3 | $0 | Hold |
110
| – | – | ﹤0.01% | 3975 |
|
|
2019
Q2 | $1K | Hold |
110
| – | – | ﹤0.01% | 3922 |
|
|
2019
Q1 | $1K | Hold |
110
| – | – | ﹤0.01% | 3926 |
|
|
2018
Q4 | $1K | Hold |
110
| – | – | ﹤0.01% | 3926 |
|
|
2018
Q3 | $1K | Hold |
110
| – | – | ﹤0.01% | 4011 |
|
|
2018
Q2 | $1K | Sell |
110
-313,786
| -100% | -$2.85M | ﹤0.01% | 4038 |
|
|
2018
Q1 | $2.99M | Buy |
313,896
+313,848
| +653,850% | +$2.99M | ﹤0.01% | 896 |
|
|
2017
Q4 | $0 | Buy |
+48
| New | – | ﹤0.01% | 4132 |
|